-
PRODUCTS
-
-
-
SERVICE
-
-
CONTACT
Blog
Get the latest news immediately and stay up-to-date with global trends!
In the global pharmaceutical industry, Singapore has gradually become a shining star in recent years, attracting the attention of numerous domestic and foreign pharmaceutical companies. Especially in the past few years, Chinese pharmaceutical companies have extended their investment tentacles to this Southeast Asian island nation. This phenomenon has sparked widespread attention and reflection: what factors have prompted Chinese pharmaceutical companies to be so enthusiastic about Singapore? Is it the temptation of policies, the potential of the market, or other deeper reasons? Meanwhile, what challenges and opportunities do Chinese pharmaceutical companies face in their development in Singapore? This article will delve into these issues in depth.
Alzheimer's disease (AD) is a terrible disease, like a merciless shadow that envelops countless patients and their families. With the intensification of global population aging, the number of Alzheimer's disease patients continues to rise, bringing a heavy burden to society and healthcare systems. However, in this long-term struggle against the disease, researchers have never stopped exploring, and the process of developing new drugs is full of twists and turns, but occasionally hope can also be seen.
In the long process of tumor treatment, surgery, chemotherapy, and radiotherapy have always been the three traditional pillar methods. With the rapid development of technology and continuous innovation in the field of radiation therapy, heavy ion therapy, as a cutting-edge technology, is gradually emerging, bringing new hope to cancer patients. This article will delve into the principles, indications, advantages, research progress, and application prospects of heavy ion radiation therapy in the field of tumor treatment.
HCZC will participate in the CPHI exhibition in Seoul, South Korea from August 27th to 29th, 2024.
2024 Seoul Pharmaceutical Raw Materials Exhibition (CPHI Korea)
Exhibition time: August 27th to August 29th, 2024
Venue: COEX Seoul Convention Center, 513 Yongdong Road, Samsung dong, Gangnam gu, Seoul, South Korea
ZCPC Pharmaceutical participated in the CPHI exhibition held in Shanghai from June 19th to 21st, 2024.
From June 19th to 21st, 2024, the 22nd CPHI China and the 17th PMEC China will be held at the Shanghai New International Expo Center, showcasing over 210000 square meters of new products, innovative equipment, and cutting-edge technologies from nearly 3500 well-known exhibitors from home and abroad. The scope of exhibits includes active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, natural extracts, etc.
Tel：+86-570-8750500-8183/8185
Fax：+86-570-8750617 / 8750612
Add：No.36 Huayang Road, Hi-tech Industry Zone Quzhou City Zhejiang, China
Jason
Tel: 0086 13357006799
WhatsApp: +86 13357006799
Email: zhl@zcpc.net
Landline：0086-0570-8750611
Eason
Steve
Copyright © 2024 Zhejiang Chemsyn Pharm Co.,Ltd.